Skip to main content
Premium Trial:

Request an Annual Quote

Neumann: Independent No More

Premium

When Eric Neumann left 3rd Millennium two months ago, he announced that he was going into independent consulting. He didn’t last long. “Two of the groups I consulted for quickly wanted to hire me,” he says. “I wasn’t prepared to have to make such a fast decision.” But after four or five job offers, Neumann, 42, left consulting behind and hopped aboard Beyond Genomics as vice president of bioinformatics.

The company, a NewcoGen venture first detailed in February 2000, employs a systems biology approach to examine the chemistry, metabolite, gene expression, and protein levels of samples. According to Neumann, “I am in charge of making sure we gather all this information in a very clean, robust way and making sure we don’t lose anything.” The idea, he says, is to merge all the data from clinical samples to “[tell] a useful story from it.” Beyond Genomics applies mass spec and NMR technology to study the data.

The company has just recently come together. President and CEO Stephen Ober joined in November, and the rest of the team signed on in the last few months. Neumann, who was recruited largely for his work with ontologies and the biopathways consortium, is building a core bioinformatics staff.

In spite of his quick move to another company, Neumann says he enjoyed consulting. “Independent consulting is great to really get a good view of the landscape,” he says. “There’s the freedom to interact with a lot of very interesting vendors and groups.”

— Meredith Salisbury

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.